InceptionR’s ImmunityBio IBRX Stock Holding History

InceptionR’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$90.8K	Buy	+10,372	New	+$78.5K	0.02%	624
2023 Q2	–	Sell	-18,302	Closed	-$33.3K	–	512
2023 Q1	$33.3K	Buy	+18,302	New	+$56.9K	0.01%	410

Other funds holding IBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

InceptionR's IBRX Position: Q2 2026 in Review

InceptionR opened a new position in ImmunityBio (IBRX) in Q2 2026: 10,372 shares worth $90.8K. The stake represents 0.02% of the portfolio and ranks #624 among its holdings. This is a return to the name: InceptionR previously reported a position in IBRX as recently as Q1 2023.

InceptionR first reported a position in IBRX in Q1 2023 and has held it in 2 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

InceptionR held 10,372 shares of ImmunityBio worth $90.8K as of Q2 2026.
ImmunityBio was a new InceptionR position in Q2 2026.
ImmunityBio made up 0.02% of InceptionR's portfolio in Q2 2026, its #624 holding.
InceptionR first reported a position in ImmunityBio in Q1 2023 and has held it in 2 quarters since.
405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.